Innovera Pharmaceuticals Private Limited
About Innovera Pharmaceuticals Private Limited
Data last updated:
Innovera Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 July 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2022PTC165298.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Renuka Tadakamalla and Chandra Sekhar Rao Juvvadi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6 – 3 – 883 6 B Punjagutta Green Lands, Hyderabad, Telangana, India – 500082.
As per the financials filed for FY 2025, the company reported a revenue of ₹26,861, a decline of 5% compared to the previous year. For the same year it recorded a net loss of ₹82,755 (net margin -308.1%) and EBITDA of -₹82,755 (EBITDA margin -308.1%).
Company details
Contact details
Innovera Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered Address6 – 3 – 883 6 B Punjagutta Green Lands, Hyderabad, Telangana, India – 500082
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Innovera Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
Financials of Innovera Pharmaceuticals Private Limited
FY 2025 filings availableInnovera Pharmaceuticals Private Limited reported revenue of ₹26,861 (down 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 5% in the latest year. EBITDA fell 57% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹82,755 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹82,755 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -308.1% | ||
| Net Profit Margin | -308.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Innovera Pharmaceuticals Private Limited, buy the company report.
Board of directors of Innovera Pharmaceuticals Private Limited
Innovera Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Renuka Tadakamalla Also directs: Trikuta Labs Limited | Director | 29 Jul 2022 | 4 Years 3 Months | Current |
| Chandra Sekhar Rao Juvvadi Also directs: Biozen Biologics Private Limited, SSV Infratech India Limited, Kriscon Infratech Private Limited and 2 more | Director | 29 Jul 2022 | 4 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Innovera Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innovera Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Innovera Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Innovera Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Chandra Sekhar Rao Juvvadi was appointed as Director on 29 Jul 2022.
Frequently asked questions
Innovera Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 July 2022 (4+ years old) and is registered under CIN U24230TG2022PTC165298.
Innovera Pharmaceuticals has 2 current directors:
- Renuka Tadakamalla - Director
- Chandra Sekhar Rao Juvvadi - Director
The latest financial statements of Innovera Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Innovera Pharmaceuticals is U24230TG2022PTC165298. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innovera Pharmaceuticals was incorporated on 29 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
Chandra Sekhar Rao Juvvadi was appointed as Director on 29 Jul 2022. Renuka Tadakamalla was appointed as Director on 29 Jul 2022.
The registered office of Innovera Pharmaceuticals is at 6 – 3 – 883 6 B Punjagutta Green Lands, Hyderabad, Telangana, India – 500082.
Innovera Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Innovera Pharmaceuticals can be reached at its registered office: 6 – 3 – 883 6 B Punjagutta Green Lands, Hyderabad, Telangana, India – 500082.
Innovera Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
